Sign in

CIK 0000948320

  • Accelerated filer

LifeMD, Inc.

Sign in to watch
Ticker
LFMD
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760238453
Phone
+1 866-351-5907
Business address
236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
Former names
CONVERSION LABS, INC., Immudyne, Inc.

Securities

  • LFMD Common Stock Nasdaq
  • LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
  1. 4 Grant or award Chief Marketing Officer acquired 150,000 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Director acquired 75,000 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award Director acquired 75,000 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy Director bought 50,000 shares at $2.14 ($106,800)
  8. 4 Open-market buy General Counsel & CCO bought 5,000 shares at $3.14 ($15,700)
  9. 4 Open-market buy Director bought 2,000 shares at $3.28 ($6,560)
  10. 4 Gift Chief Acquisition Officer gave 60,000 shares (gift)
  11. 4 Gift CEO gave 60,000 shares (gift)
  12. 4 Option exercise President acquired 22,000 shares (option exercise)
  13. 5 Insider Annual Insider Trading Report
  14. 5 Insider Annual Insider Trading Report
  15. 4 Option exercise Principal Accounting Officer acquired 5,000 shares (option exercise)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Option exercise General Counsel & CCO acquired 12,500 shares (option exercise)
  18. 4 Option exercise Chief Financial Officer acquired 25,000 shares (option exercise)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 6 of 12 · 230 filings